USANA Health Sciences (USNA) Tops Q3 EPS by 7c; offers FY24 guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $12.86 -3.81%
Financial Fact:
Earnings before income taxes: 36.1M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Earnings before income taxes: 36.1M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.56, $0.07 better than the analyst estimate of $0.49. Revenue for the quarter came in at $200.22 million versus the consensus estimate of $206.14 million.
GUIDANCE:
USANA Health Sciences sees FY2024 EPS of $2.40-$2.55, versus the consensus of $2.50. USANA Health Sciences sees FY2024 revenue of $850-880 million, versus the consensus of $861.9 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
